A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. (vol 6, pg 798, 2000)
I. Ganly, A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. (vol 6, pg 798, 2000), CLIN CANC R, 6(5), 2000, pp. 2120-2120